BAUDAX BIO Trademark

Trademark Overview

On Wednesday, August 7, 2019, a trademark application was filed for BAUDAX BIO with the United States Patent and Trademark Office. The USPTO has given the BAUDAX BIO trademark a serial number of 88980271. The federal status of this trademark filing is REGISTERED as of Tuesday, March 1, 2022. This trademark is owned by Recro Enterprises, Inc.. The BAUDAX BIO trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and biological preparations for medical or pharmaceutical use, namely, preparations for the treatment of acute critical care conditions; pharmaceutical preparations for the treatment of acute critical care conditions; pharmaceutical preparations for the prevention and treatment of pain; pharmaceutical preparations for the treatment of pain management by intravenous or intramuscular delivery

Development of pharmaceutical and biological preparations
baudax bio

General Information

Serial Number88980271
Word MarkBAUDAX BIO
Filing DateWednesday, August 7, 2019
Status700 - REGISTERED
Status DateTuesday, March 1, 2022
Registration Number6660479
Registration DateTuesday, March 1, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 2, 2020

Trademark Statements

Goods and ServicesPharmaceutical and biological preparations for medical or pharmaceutical use, namely, preparations for the treatment of acute critical care conditions; pharmaceutical preparations for the treatment of acute critical care conditions; pharmaceutical preparations for the prevention and treatment of pain; pharmaceutical preparations for the treatment of pain management by intravenous or intramuscular delivery
Disclaimer with Predetermined Text"BIO"
Goods and ServicesDevelopment of pharmaceutical and biological preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 23, 2019
Primary Code005
First Use Anywhere DateMonday, March 30, 2020
First Use In Commerce DateMonday, March 30, 2020
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 23, 2019
Primary Code042
First Use Anywhere DateMonday, March 30, 2020
First Use In Commerce DateMonday, March 30, 2020

Trademark Owner History

Party NameBAUDAX BIO, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMALVERN, PA 19355
Party NameBAUDAX BIO, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMALVERN, PA 19355
Party NameBAUDAX BIO, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressMALVERN, PA 19355
Party NameRecro Enterprises, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMalvern, PA 19355

Trademark Events

Event DateEvent Description
Tuesday, March 1, 2022REGISTERED-PRINCIPAL REGISTER
Wednesday, January 26, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 26, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, January 26, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 26, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, January 22, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, January 21, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, December 21, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 21, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 14, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 15, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 15, 2021NON-FINAL ACTION E-MAILED
Tuesday, June 15, 2021SU - NON-FINAL ACTION - WRITTEN
Wednesday, May 5, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 5, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 30, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 5, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 5, 2021NON-FINAL ACTION E-MAILED
Friday, February 5, 2021SU - NON-FINAL ACTION - WRITTEN
Thursday, January 21, 2021STATEMENT OF USE PROCESSING COMPLETE
Tuesday, December 22, 2020USE AMENDMENT FILED
Thursday, January 21, 2021DIVISIONAL PROCESSING COMPLETE
Tuesday, December 22, 2020DIVISIONAL REQUEST RECEIVED
Monday, January 11, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 22, 2020TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, December 22, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, July 28, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 2, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 2, 2020PUBLISHED FOR OPPOSITION
Wednesday, May 13, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 28, 2020ASSIGNED TO LIE
Wednesday, April 22, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 1, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 1, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 1, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, February 26, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, February 19, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, February 19, 2020FINAL REFUSAL E-MAILED
Wednesday, February 19, 2020FINAL REFUSAL WRITTEN
Wednesday, January 29, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 28, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 28, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 12, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 12, 2019NON-FINAL ACTION E-MAILED
Tuesday, November 12, 2019NON-FINAL ACTION WRITTEN
Wednesday, November 6, 2019ASSIGNED TO EXAMINER
Friday, August 23, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, August 10, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

baudax pharmaceutical preparations treatment pain conditions critical care acute biological intramuscular